Top Path Asia Ltd 13D/13G Filings for Sorrento Therapeutics, Inc. (SRNE)

Top Path Asia Ltd 13D and 13G filings for Sorrento Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-01
4:33 pm
Sale
2020-12-31 13G Sorrento Therapeutics, Inc.
SRNE
Top Path Asia Ltd 0
0.000%
-6,831,955decrease
(Position Closed)
Filing